>
The Greatest Crime Against Humanity
Biden Calls for 44.6% Capital Gains Tax Rate, Highest Capital Gains Tax Since Its Creation in 1922
Overconfidence In NFL Drafts: A Lesson For Investors
USDA's $1.5 Billion Targets 180,000 Farms, 225 Million Acres for 30×30
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
But increasing the quantity of a certain drug you're taking may lead to serious consequences, like in the case of the Parkinson's drug, levodopa (L-dopa).
Gut microbes and L-dopa
L-dopa is a replacement for dopamine commonly prescribed to patients with Parkinson's disease. Considered the most potent medication for the disease, this drug is meant to be converted in the brain into dopamine, the chemical involved in controlling movement. But the effects of L-dopa vary between patients, and human and animal studies have linked the discrepancy to microorganisms found in the human gut.
Each person has a unique composition of gut microbes. In some patients, L-dopa doesn't produce the desired results because certain microorganisms in their gut interfere with the drug's activity. These microbes break down L-dopa before it can reach the blood-brain barrier — the selective membrane that protects the brain from potentially harmful substances in the blood. This interference renders the drug ineffective.
In a recent study published in Science, researchers from Harvard University and the University of California, San Francisco finally put a name to these mysterious microbes. After screening gut bacterial genomes and conducting biochemical analyses, they identified Enterococcus faecalis and Eggerthella lenta as the two microbes that metabolize L-dopa in the gut.
The researchers found that E. faecalis produces an enzyme that converts L-dopa into dopamine, but an enzyme produced by E. lenta then transforms dopamine into m-tyramine. While the effects of this second conversion is still unclear, the researchers believe it may be linked to the side effects associated with L-dopa metabolism outside the brain.